Jul 2026· PLOS Global Public Health· Vol 6, pp. e0006682· 0 citations· 18 references
Medicine
TL;DR
The apparent link between vaccine category and coverage largely reflected differences in economic capacity, geographic region, and deployment context rather than vaccine category itself.
Abstract
We examined whether COVID-19 vaccine type was associated with national full-vaccination coverage using 1034 country–vaccine entries from 195 countries derived from World Health Organization data. In a country-level analysis adjusting for World Bank income group, WHO region, and the number of vaccine products per country, neither mRNA vaccine availability (p = 0.051) nor the proportion of mRNA vaccines in a country’s portfolio (p = 0.164) was significantly associated with coverage. Vaccine-related variables added only one percentage point to the explained variance beyond structural factors (ΔR2=0.011). Unadjusted exploratory analyses showed that some vaccine products were more frequently recorded in high-coverage country contexts, but these patterns were substantially attenuated after adjustment for structural covariates. The apparent link between vaccine category and coverage largely reflected differences in economic capacity, geographic region, and deployment context rather than vaccine category itself.
In the early stage of rollout, higher maternal mortality was associated with lower coverage, while a larger urban population was associated with higher coverage, while a larger health expenditure and a larger urban population were associated with higher coverage.
H.-W. Lee, Y.-H. Huang, T. McAndrew· medRxiv· 0 citations
This paper examines whether mandatory COVID-19 vaccination policies generated spillover effects on the uptake of other vaccines. Using a global country-year panel, we combine COVID-19 vaccine mandate data from the Oxford COVID-19 Government Response Tracker with international vaccination coverage data for discretiona...
Sahar F. Yousef, M. Abu-Zaineh, Pierre Verger et al.· npj Vaccines· 0 citations
A pronounced HVE was observed for SARS-CoV-2 vaccination during the pandemic, evidenced by markedly lower mortality from causes not plausibly related to vaccination (cancer, external causes) among vaccinated individuals.
U. Riedmann, H. Brenner, J. Ioannidis et al.· medRxiv· 0 citations
COVID‑19 vaccination in Nigeria has been investigated through administrative reports, household and telephone surveys, facility-based studies, qualitative enquiries and digital interventions. Their findings are difficult to reconcile because willingness, hesitancy, receipt of a first dose and completion of vaccination...
Charity Ifenyinwa OKorogba, Peter Aduvie Josiah· Journal of disease and globa...· 0 citations
BACKGROUND
Although safe and effective human papillomavirus (HPV) vaccines have been available since 2006, national introduction in low- and middle-income countries (LMICs) has progressed slowly. HPV vaccine adoption may have been shaped by evolving World Health Organization (WHO) recommendations, funding policies of G...
Jiyeon Suh, M. Brisson, E. Burger et al.· Expert Review of Vaccines· 0 citations
While the COVID-19 crisis has dropped, the geographic clustering identified in this study may be continue as epicenters of hesitancy for future vaccine rollouts, including the nationally planned rollouts for hepatitis B birth dose, malaria, and cholera in Ethiopia.
Abiyu Abadi Tareke, A. Keleb, Natnael Kebede et al.· BMC Public Health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
